An artificial cell with a full lifecycle has been created for the first time
For the first time, researchers have created an artificial cell capable of a complete lifecycle, including growth, division, and gene expression. This synthetic cell, built from a minimal set of genes, marks a significant milestone in synthetic biology by demonstrating self-replication and the ability to evolve.
Background
- This article reports a milestone in synthetic biology: researchers have created a single "artificial cell" that can grow, divide, and reproduce through multiple generations — something that had never been achieved before.
- The cell is not built entirely from scratch; it uses a synthetic genome (a lab-made copy of a minimal bacterial genome) inserted into a hollowed-out shell of a natural bacterium. The breakthrough is that this cell successfully completed a full life cycle (growth, DNA replication, division, and continued reproduction) under lab conditions.
- The work builds on earlier pioneering efforts by J. Craig Venter's institute, which produced the first synthetic bacterial genome in 2010 and a minimal genome in 2016. The new development adds the ability to sustain a complete, self-reproducing life cycle.
- Why it matters: Creating a cell with a full life cycle is a step toward designing custom organisms for specific tasks (e.g., producing drugs, breaking down pollutants, or manufacturing materials) with predictable behavior. It also deepens understanding of the fundamental requirements for life.
A tweet by Kevin A. Bryan highlights what he describes as an incredible breakthrough in synthetic biology, noting it has been a great year for scientific progress. The post links to a New York Times article about "spudcells" and synthetic cells.
Longitudinal single-cell data from Sid's cancer treatment was analyzed using Incytr, revealing neutrophils shifted from receivers to pro-tumor signal senders, resistant to immunotherapy but partially reversed by FAPI radiotherapy. Spatial analysis showed increasing T cell accumulation and oncolytic virus presence in the tumor bed.